LifeStance Health Group Inc (LFST)’s latest performance is not what we had anticipated

LifeStance Health Group Inc (NASDAQ: LFST) kicked off on Monday, up 5.27% from the previous trading day, before settling in for the closing price of $6.64. Over the past 52 weeks, LFST has traded in a range of $4.63-$9.59.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

Annual sales at Healthcare sector company grew by 61.07% over the past five years. While this was happening, its average annual earnings per share was recorded 20.68%. With a float of $85.76 million, this company’s outstanding shares have now reached $375.96 million.

LifeStance Health Group Inc (LFST) Insider Updates

Our next focus will be how large-scale investors are participating in this stock of the Medical Care Facilities Industry. The insider ownership of LifeStance Health Group Inc is 77.35%, while institutional ownership is 20.75%. The most recent insider transaction that took place on Dec 01, was worth 741,204. In this transaction Chief Development Officer of this company sold 113,334 shares at a rate of $6.54, taking the stock ownership to the 4,690,616 shares. Before that another transaction happened on Nov 07, when Company’s Chief Development Officer sold 32,056 for $6.12, making the entire transaction worth $196,183. This insider now owns 4,803,950 shares in total.

LifeStance Health Group Inc (LFST) Performance Highlights and Predictions

Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.21 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 20.68% per share during the next fiscal year.

LifeStance Health Group Inc (NASDAQ: LFST) Trading Performance Indicators

Take a look at LifeStance Health Group Inc’s (LFST) current performance indicators. Last quarter, stock had a quick ratio of 1.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.63.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.51, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.30 in one year’s time.

Technical Analysis of LifeStance Health Group Inc (LFST)

LifeStance Health Group Inc (NASDAQ: LFST) saw its 5-day average volume 1.06 million, a negative change from its year-to-date volume of 1.36 million. As of the previous 9 days, the stock’s Stochastic %D was 97.20%. Additionally, its Average True Range was 0.41.

During the past 100 days, LifeStance Health Group Inc’s (LFST) raw stochastic average was set at 68.75%, which indicates a significant decrease from 97.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.94% in the past 14 days, which was higher than the 53.73% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $6.91, while its 200-day Moving Average is $7.47. Nevertheless, the first resistance level for the watch stands at $7.13 in the near term. At $7.26, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.53. If the price goes on to break the first support level at $6.73, it is likely to go to the next support level at $6.46. Assuming the price breaks the second support level, the third support level stands at $6.33.

LifeStance Health Group Inc (NASDAQ: LFST) Key Stats

The company with the Market Capitalisation of 2.65 billion has total of 378,607K Shares Outstanding. Its annual sales at the moment are 859,540 K in contrast with the sum of -215,560 K annual income. Company’s last quarter sales were recorded 262,900 K and last quarter income was -61,580 K.